PSYRX BIO-TECH
Sector: Healthcare & Life Sciences
About PSYRX BIO-TECH
PsyRx Molecules Applications Technology Team In The Media Investors Us Next Generation Therapeutics for Mental Health Disorders Advancing novel molecules designed to enhance brain plasticity and address the limitations of current treatments Discover how Our goal is to lead the development of combination therapies that enhance neuroplasticity and improve psychiatric outcomes. Once daily oral dosage form No supervision Designed for efficacy with minimal side effects No interruption to daily lifestyle Transforming mental health Our lead drug candidate is a fixed-dose combination of an SSRI and a
Products
Ibogaine
A powerful compound derived from the root bark of the iboga tree (Tabernanthe iboga), native to Central and West Africa. Ibogaine is at the forefront of cutting-edge research being developed not only as a promising treatment for addiction but also for its potential to revolutionize depression therapy by enhancing neuroplasticity and addressing treatment-resistant cases.